Evofem Return on Average Equity from 2010 to 2024
| EVFMDelisted Stock | USD 0.05 0.0001 0.21% |
Check Evofem Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Evofem main balance sheet or income statement drivers, such as , as well as many exotic indicators such as . Evofem financial statements analysis is a perfect complement when working with Evofem Biosciences Valuation or Volatility modules.
Evofem |
About Evofem Biosciences Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Evofem Biosciences income statement, its balance sheet, and the statement of cash flows. Evofem Biosciences investors use historical funamental indicators, such as Evofem Biosciences's Return on Average Equity, to determine how well the company is positioned to perform in the future. Although Evofem Biosciences investors may use each financial statement separately, they are all related. The changes in Evofem Biosciences's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Evofem Biosciences's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Evofem Biosciences Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Evofem Biosciences. Please read more on our technical analysis and fundamental analysis pages.
Evofem Biosciences, Inc., a biopharmaceutical company, develops and commercializes various products to address unmet needs in womens sexual and reproductive health. Evofem Biosciences, Inc. is headquartered in San Diego, California. Evofem Biosciences operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 119 people.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Evofem Biosciences in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Evofem Biosciences' short interest history, or implied volatility extrapolated from Evofem Biosciences options trading.
Pair Trading with Evofem Biosciences
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Evofem Biosciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Evofem Biosciences will appreciate offsetting losses from the drop in the long position's value.Moving together with Evofem OTC Stock
| 0.73 | KA | Kineta Inc Financial Report 9th of May 2024 | PairCorr |
Moving against Evofem OTC Stock
| 0.77 | YS | YS Biopharma Report 22nd of April 2024 | PairCorr |
| 0.76 | VERU | Veru Inc Buyout Trend | PairCorr |
| 0.71 | VCEL | Vericel Corp Ord Downward Rally | PairCorr |
| 0.7 | DOMH | Dominari Holdings | PairCorr |
| 0.59 | DNTH | Dianthus Therapeutics Symbol Change | PairCorr |
The ability to find closely correlated positions to Evofem Biosciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Evofem Biosciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Evofem Biosciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Evofem Biosciences to buy it.
The correlation of Evofem Biosciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Evofem Biosciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Evofem Biosciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Evofem Biosciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in census. Note that the Evofem Biosciences information on this page should be used as a complementary analysis to other Evofem Biosciences' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Consideration for investing in Evofem OTC Stock
If you are still planning to invest in Evofem Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Evofem Biosciences' history and understand the potential risks before investing.
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |